BioAlliance Pharma SA announces that it has just received the following press release from Immtech Pharmaceuticals, Inc., the US company from which it has licensed the European rights for pafuramidine.
Xilinx, Inc. announced that it is a gold sponsor of the 21st International Conference on VLSI Design and 7th International Conference on Embedded Systems, taking place from January 4 through 8, 2008 at the Hyderabad International Convention Centre.
Arrowhead Research Corporation announced today that its President & CEO, Christopher Anzalone, will present at the 10th Annual Needham Growth Stock Conference on Wednesday, January 9, 2008 at 3:00 pm ET in New York City.
Unidym, a majority-owned subsidiary of Arrowhead Research Corp., announced that Unidym's founder, Professor George Gruner, has been selected as a visionary Technology Pioneer for 2008 by the World Economic Forum and has been invited to speak at the upcoming WEF Technology Pioneers Conference in Davos, Switzerland, this January.
CANEUS has announced that the CANEUS Organization has partnered with the French Space Agency - CNES to host the international 'MNT Reliability for Aerospace' Workshop in Toulouse, France, from March 6-7, 2008.
Ener1, Inc., an alternative energy company, announced that the United States Senate approved funding of $1 million to its EnerDel subsidiary for research to develop, produce and evaluate superior battery technology for mass transit hybrid electric buses.
US demand for biocompatible materials will increase 6.6 percent annually to $3.7 billion in 2010. Gains will match the overall upward pace of end-use product shipments as stricter FDA pre-market approval and production standards mandate the upgrading of materials used in medical and dental implants and drug delivery systems.
Cymbet Corporation today announced that Dr. Stephen W. Downey, director of technology at Cymbet, presented at the Semiconductor Research Council/National Science Foundation Forum on Nano-Morphic Systems: Processes, Devices and Architectures.
ASML Holding NV and Carl Zeiss SMT today announce that each has signed an agreement with Canon Inc. for the global cross-license of patents in their respective fields of semiconductor lithography and optical components, used to manufacture integrated circuits.